doi: 10.1039/D4FO00987H 13 PeiLXieLWuJZhangHZhangX
How PlexusDx Supports a More Personalized Approach PlexusDx's Precision Peptide Genetic Test may help provide context regarding genetic predispositions in peptide-related pathways, though the test is designed for GLP-1 and GIP signaling, not GHK-Cu metabolism directly
It affects about 1 in 200 people in North America and Europe, which is quite a lot of people, with lower but increasing prevalence in Asia, Africa, and other countries
At Optimal Health Medical, the focus is personalization, medical supervision, realistic expectations, and follow-up
GHK and DNA: resetting the human genome to health